SEC 13F Intelligence

Skandinaviska Enskilda Banken AB (Publ) / CVS

Skandinaviska Enskilda Banken AB (Publ)’s Cvs Health Corp Position

Does Skandinaviska Enskilda Banken AB (Publ) own Cvs Health Corp (CVS)? Not currently — the last reported position was 833.8K shares worth $66M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$66M
Q4 2025
Shares
833.8K
% of Portfolio
+0.27%
Quarters Held
29
position exited

Position History CVS

Reported value by quarter
Q4 ’18: $246MQ4 ’18Q1 ’19: $24MQ2 ’19: $12MQ3 ’19: $15MQ4 ’19: $17MQ4 ’19Q1 ’20: $14MQ2 ’20: $19MQ3 ’20: $19MQ4 ’20: $22MQ4 ’20Q1 ’21: $27MQ2 ’21: $29MQ3 ’21: $31MQ4 ’21: $33MQ4 ’21Q1 ’22: $46MQ2 ’22: $74MQ3 ’22: $70MQ4 ’22: $60,454Q4 ’22Q1 ’23: $29,854Q2 ’23: $25,745Q3 ’23: $23,791Q4 ’23: $21MQ4 ’23Q1 ’24: $20MQ2 ’24: $15MQ3 ’24: $16MQ4 ’24: $11MQ4 ’24Q1 ’25: $38MQ2 ’25: $52MQ3 ’25: $56MQ4 ’25: $66MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2025833.8K$66M+0.27%
Q3 2025748.8K$56M+0.23%
Q2 2025756.4K$52M+0.23%
Q1 2025565.2K$38M+0.19%
Q4 2024254.1K$11M+0.05%
Q3 2024254.9K$16M+0.07%
Q2 2024255.4K$15M+0.07%
Q1 2024250.1K$20M+0.10%
Q4 2023271.6K$21M+0.12%
Q3 2023340.7K$23,791+0.16%
Q2 2023372.4K$25,745+0.17%
Q1 2023401.7K$29,854+0.21%
Q4 2022648.7K$60,454+0.45%
Q3 2022734.2K$70M+0.54%
Q2 2022802.9K$74M+0.55%
Q1 2022458.4K$46M+0.27%
Q4 2021317.2K$33M+0.17%
Q3 2021370.0K$31M+0.17%
Q2 2021350.8K$29M+0.18%
Q1 2021357.2K$27M+0.18%
Q4 2020322.5K$22M+0.15%
Q3 2020325.9K$19M+0.14%
Q2 2020289.2K$19M+0.15%
Q1 2020242.2K$14M+0.15%
Q4 2019222.7K$17M+0.13%
Q3 2019234.8K$15M+0.13%
Q2 2019215.9K$12M+0.10%
Q1 2019444.3K$24M+0.22%
Q4 20183.76M$246M+2.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Skandinaviska Enskilda Banken AB (Publ)’s full portfolio or all institutional holders of CVS.